Morgan Stanley initiated coverage on three AI-integrated biotechnology firms, Absci, Schrodinger (NASDAQ:SDGR), and Recursion Pharmaceuticals, flagging divergent business models and upcoming catalysts ...

Morgan Stanley stock hit a new 52-week high, climbing to $142.63 on strong trading volume. The financial powerhouse reported ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent ...

Morgan Stanley (MS) is currently at $142.31, up $1.24 or 0.88% --Would be new all-time closing high (Based on available data back to Feb. 23, 1993) --Would be the first record close since Feb. 6, 2025 ...

Buying $1000 In MS: If an investor had bought $1000 of MS stock 5 years ago, it would be worth $2,906.60 today based on a price of $141.90 for MS at the time of writing.

U.S. stock-indices SPX DJIA COMP are higher at the opening bell as benchmark Treasury yields BX:TMUBMUSD10Y fall. The dollar index DXY is down, while oil prices (CL.1) rise and gold (GC00) is trading ...

Regulatory relief on SLR will unlock significant capital returns for Morgan Stanley. Click here to read I am upgrading MS ...

Nu Holdings Ltd. (NYSE:NU) is one of the 12 Best Stocks to Buy and Hold for the Long Term. On June 13, analyst Jorge Kuri ...

Morgan Stanley analyst Sanjit Singh assumed Snowflake with an Overweight rating on Tuesday and set a price target of $262, citing improvement in secular growth trends.

Roughly 200 advisors at the firm are being named "founder specialists" for their track record helping entrepreneurs do ...

Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases. Morgan Stanley in Focus ...